SILINGARDI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 9.206
EU - Europa 4.365
AS - Asia 3.930
SA - Sud America 537
Continente sconosciuto - Info sul continente non disponibili 251
AF - Africa 105
OC - Oceania 27
Totale 18.421
Nazione #
US - Stati Uniti d'America 8.965
IT - Italia 1.317
GB - Regno Unito 1.144
SG - Singapore 1.097
CN - Cina 1.090
SE - Svezia 454
HK - Hong Kong 421
BR - Brasile 388
VN - Vietnam 366
DE - Germania 274
FI - Finlandia 246
UA - Ucraina 234
TR - Turchia 221
FR - Francia 198
BD - Bangladesh 190
RU - Federazione Russa 183
IN - India 114
CA - Canada 113
KR - Corea 109
BG - Bulgaria 73
ID - Indonesia 53
AR - Argentina 46
NL - Olanda 43
MX - Messico 41
MY - Malesia 32
ES - Italia 31
IQ - Iraq 31
PK - Pakistan 31
ZA - Sudafrica 29
CO - Colombia 28
PL - Polonia 27
AU - Australia 24
JP - Giappone 24
EC - Ecuador 23
SA - Arabia Saudita 21
CL - Cile 20
BZ - Belize 19
IE - Irlanda 18
RO - Romania 18
AE - Emirati Arabi Uniti 17
CZ - Repubblica Ceca 17
BE - Belgio 16
IR - Iran 15
JM - Giamaica 15
CR - Costa Rica 14
PH - Filippine 14
AT - Austria 13
KE - Kenya 13
NP - Nepal 13
MA - Marocco 12
VE - Venezuela 12
ET - Etiopia 11
LT - Lituania 11
EG - Egitto 9
TH - Thailandia 9
CH - Svizzera 8
HN - Honduras 8
DZ - Algeria 7
EU - Europa 7
JO - Giordania 7
TN - Tunisia 7
UZ - Uzbekistan 7
GT - Guatemala 6
HU - Ungheria 6
KZ - Kazakistan 6
PE - Perù 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
AZ - Azerbaigian 5
DK - Danimarca 5
GE - Georgia 5
IL - Israele 5
SC - Seychelles 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
EE - Estonia 4
MD - Moldavia 4
RS - Serbia 4
SV - El Salvador 4
AL - Albania 3
AM - Armenia 3
BH - Bahrain 3
CM - Camerun 3
KG - Kirghizistan 3
MK - Macedonia 3
PR - Porto Rico 3
AN - Antille olandesi 2
LB - Libano 2
LK - Sri Lanka 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AG - Antigua e Barbuda 1
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
Totale 18.153
Città #
Ashburn 1.128
Santa Clara 865
Southend 778
Singapore 677
San Jose 511
Fairfield 493
Chandler 455
Council Bluffs 452
Jacksonville 435
Hong Kong 401
Hefei 380
Woodbridge 321
Dearborn 319
Houston 246
Wilmington 227
Nyköping 212
Beijing 205
Ann Arbor 203
Cambridge 192
Los Angeles 165
Helsinki 164
Seattle 164
London 159
Izmir 113
Milan 112
Ho Chi Minh City 108
New York 108
The Dalles 107
Buffalo 102
Princeton 86
Chicago 84
Hanoi 82
Seoul 80
San Diego 73
Rome 72
Eugene 71
Sofia 71
Columbus 68
Des Moines 63
Lauterbourg 57
Moscow 51
Jakarta 45
Dong Ket 44
São Paulo 42
Falls Church 39
Dallas 37
Shanghai 34
Bremen 31
Orem 30
Phoenix 30
Toronto 28
Naples 27
Salt Lake City 27
Munich 26
Turin 26
Montreal 24
Da Nang 22
Redwood City 21
Belize City 19
Chennai 19
Tokyo 19
Modena 18
Bari 17
Denver 17
Frankfurt am Main 17
Norwalk 17
Palermo 17
Washington 17
Brooklyn 16
Brussels 16
Guangzhou 16
Mexico City 15
Warsaw 15
Baghdad 14
Boston 14
Johannesburg 14
Tampa 14
Verona 14
Atlanta 13
Bologna 13
Brno 13
Buraidah 13
Dublin 13
Falkenstein 13
Ottawa 13
Saint Petersburg 13
San Mateo 13
Turku 13
Boardman 12
Florence 12
Nanjing 12
Philadelphia 12
Saint Louis 12
Kunming 11
Miami 11
San Francisco 11
Elk Grove Village 10
Genoa 10
Haiphong 10
Madrid 10
Totale 11.781
Nome #
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 835
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 591
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 502
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 413
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes. 367
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 360
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 347
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS 340
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. 340
Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting 327
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 327
PROMECE-CYTABOM VS MACOP-B IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - LONG-TERM RESULTS OF A MULTICENTER STUDY OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL) 320
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL 317
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: The Gruppo Italiano per lo Studio dei Linfomi Experience 316
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer 313
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 312
A report of seven long survivors for evidence of prognostic factors in hairy cell leukemia 304
STIFF-MAN SYNDROME IN A PATIENT WITH HODGKINS-DISEASE - AN UNUSUAL PARANEOPLASTIC SYNDROME 303
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 302
A pilot study on the use of the ProMACE CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma 299
HAIRY-CELL LEUKEMIA - A CLINICAL REVIEW BASED ON 725 CASES OF THE ITALIAN-COOPERATIVE-GROUP (ICGHCL) 296
Trapianto di midollo osseo nelle aplasie midollari. 293
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 290
Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin 275
Hereditary risk of breast cancer: not only brca 274
Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study 271
Bone marrow infiltration in Hairy cell leukemia after interferon therapy detected by magnetic resonance imagin 267
Alimentazione e tumori II. Le vitamine 266
Leucemia e tricoleucociti: studio clinico patologico di 30 casi 266
Validation of the international prognostic index in working formulation group a low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo studio dei linfomi registry. 265
Prevention of cisplatin induced vomiting in patients with cancer. A pilot study with a multiagent protocol 264
ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+/KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS 262
Comment on "Cancer genetic counselling' by P.!Mandich et al. (Ann Oncol 2005; 16: 171) 261
A multicenter randomized trial of two different ProMACE-CytaBOM derived protocols in aggressive non-Hodgkin's Lymphomas (NHL). A preliminary report 259
Hodgkin's disease prognosis: a directly predictive equation 257
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monodenopathic variety 254
Screening clinico, mammografico e genetico del carcinoma mammario ereditario 253
Detection of bone marrow involvement in patients with cancer 252
Profilassi del vomito nei pazienti affetti da linfoma non-Hodgkin trattati con il protocollo ProMECE-CytaBOM. Risultati preliminari di uno studio clinico controllato 250
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease 245
Usefulness of breast MRI in a patient with genetic risk 243
Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form 238
Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL) 238
Studio clinico immunologico di sei casi di morbo di Behcet 238
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group 222
Alimentazione e tumori I. Considerazioni dietetiche generali: gli alimenti 222
Human lymphoblastoid interferon as initial therapy in hairy cell leukemia: a multicenter study in non-splenectomized patients 221
Alimentazione e tumori III. Gli oligoelementi 219
Istiocitosi maligna 218
Hairy cell leukemia: a reversible disease? A report of two cases of spontaneous remission 215
Utilità della Risonanza Magnetica Nucleare nello studio del midollo osseo di pazienti affetti da hairy Cell Leukemia 212
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades 212
The excretion of tryptophan metabolites in patients with different forms of haemoblastosis 211
Long term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian cooperative group for HCL 207
Ruolo attuale della chemioterapia nel carcinoma transizionale della vescica muscolo-invasivo 201
PROMACE-CYTABOM VERSUS MACOP-B IN INTERMEDIATE AND HIGH-GRADE NHL - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL 198
Gli interferoni in terapia antineoplastica 197
Utilità diagnostica della risonanza magnetica nucleare in onco-ematologia 195
La chemioprevenzione del carcinoma mammario 195
Free from failure survival in Hodgkin's disease. Long term analysis of 148 cases treated with a MOPP modified protocol 185
REGIMEN-RELATED LIVER TOXICITY IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION 182
Cancer Incidence in the Province of Modena. Cancer Incidence in Five Continents Vol.VII 182
La strategia terapeutica del GISL nei linfomi non-Hodgkin 181
La predisposizione genetica al cancro dell'ovaio. Individuazione e sorveglianza delle donne a rischio 170
METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN AND CISPLATIN (M-VEC) IN PATIENTS WITH LOCALLY ADVANCED TRANSITIONAL BLADDER-CANCER 168
Immunohistochemical labeling index in breast cancer after in vivo administration of bromodeoxiuridine 153
Emopoiesi extramidollare endotoracica in Morbo di Cooley dell'adulto 134
Biological and clinical featuresof BRCA1and BRCA2 related tumors 78
BrCa1 mutational analysis in a population of Italian women affected by hereditary breast or breast/ovarian cancer 31
Totale 18.421
Categoria #
all - tutte 61.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022996 0 0 0 129 40 105 72 64 149 73 223 141
2022/20231.403 123 130 109 125 180 238 18 131 173 24 58 94
2023/2024826 44 45 50 84 147 68 143 66 9 34 35 101
2024/20252.874 117 39 50 222 609 422 221 201 319 84 279 311
2025/20265.046 298 264 506 362 569 477 569 218 544 473 447 319
2026/20271.618 249 343 444 582 0 0 0 0 0 0 0 0
Totale 18.421